Tag archive for ‘multiple sclerosis drug’
Vered Weiss On Thursday, October 16th, 2014

Initial U.S. Supreme Court Hearing Mixed on Teva’s Pharmaceuticals Patent Protection

– Leading Israeli Pharmaceutical company Teva has mixed results in its initial U.S. Supreme Court hearing over the possible loss of patent protection for Copaxone, a multiple sclerosis drug that accounts More...

Shiri Habib-Valdhorn On Wednesday, January 22nd, 2014

Teva Petitions US Supreme Court Over Copaxone Ruling

– Teva expects the Supreme Court to hear the case in April, a month before the Copaxone patents expire. – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has asked the US Supreme More...

Wordpress site Developed by Fixing WordPress Problems